...
首页> 外文期刊>Turkish journal of chemistry >Naphthoxazoles and heterobenzoxazoles: cholinesterase inhibition and antioxidant activity
【24h】

Naphthoxazoles and heterobenzoxazoles: cholinesterase inhibition and antioxidant activity

机译:萘恶唑和杂苯并恶唑:抑制胆碱酯酶和抗氧化活性

获取原文

摘要

Finding novel cholinesterase inhibitors that would be able to cross the blood--brain barrier, have favorable pharmacokinetic parameters, and reduce hepatotoxicity along with other side effects has been the main focus of investigations dealing with Alzheimer disease. In this study we evaluated cholinesterase inhibitory and antioxidant activity of seven oxazole derivatives. These compounds have been efficiently and sustainably prepared by photochemical electrocyclization reaction. Various naphthoxazoles have been previously investigated as potential antibacterial, antituberculosis, and anticancer agents. They have also been tested for antioxidant activity, but never for cholinesterase inhibitory activity. Among the tested oxazole derivatives, fused heterobenzoxazole compounds with pyridine and thiophene moiety, oxazolo[5,4-$h$]isoquinoline, thieno[2',3':5,6]benzo[1,2-$d$]oxazole, and thieno[3',2':5,6]benzo[1,2-$d$]oxazole, showed the greatest potential for both cholinesterase inhibitory and antioxidant activity. Among them, thieno[2',3':5,6]benzo[1,2-$d$]oxazole was found to be the best one.
机译:寻找能够穿越血脑屏障,具有良好的药代动力学参数,降低肝毒性以及其他副作用的新型胆碱酯酶抑制剂,一直是阿尔茨海默氏病研究的主要重点。在这项研究中,我们评估了7种恶唑衍生物的胆碱酯酶抑制和抗氧化活性。这些化合物已经通过光化学电环化反应有效且可持续地制备。先前已经研究了各种萘甲唑类作为潜在的抗菌剂,抗结核药和抗癌药。还对它们的抗氧化活性进行了测试,但对胆碱酯酶的抑制活性从未进行过测试。在测试的恶唑衍生物中,具有吡啶和噻吩部分的稠合杂苯并恶唑化合物,恶唑并[5,4- $ h $]异喹啉,噻吩并[2',3':5,6]苯并[1,2- $ d]恶唑,和噻吩并[3',2':5,6]苯并[1,2- $ d $]恶唑显示出最大的胆碱酯酶抑制和抗氧化活性潜力。其中,噻吩并[2',3':5,6]苯并[1,2- $ d $]恶唑是最好的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号